Literature DB >> 3190001

Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung.

T Shirakusa1, M Tsutsui, R Motonaga, K Ando, T Kusano.   

Abstract

The analysis of the data resulting from 58 operations for metastatic lung tumors is presented. The surgical procedures performed were unilateral lung tumor resection in 27 cases and bilateral lung tumor resection in 13 cases. The total cumulative five year survival rate was 41 per cent. The resected tumors were divided into two types according to the histologic appearance of the tumor margin: infiltrative and non-infiltrative (pseudo-capsulated). The cumulative five year survival rates were 14.7 per cent and 53.2 per cent, respectively. Lymph node metastasis was found in four patients with the infiltrative type of metastatic tumor.

Entities:  

Mesh:

Year:  1988        PMID: 3190001

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

2.  Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases.

Authors:  Min-Su Park; Nam-Joon Yi; Sang-Yong Son; Tae You; Suk-Won Suh; Young Rok Choi; Hyeyoung Kim; Geun Hong; Kyoung Bun Lee; Kwang-Woong Lee; Seung-Yong Jeong; Kyu Joo Park; Kyung-Suk Suh; Jae-Gahb Park
Journal:  Ann Surg Treat Res       Date:  2014-06-24       Impact factor: 1.859

3.  Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma.

Authors:  Rick Jordan; Satish Patel; Hai Hu; James Lyons-Weiler
Journal:  Cancer Inform       Date:  2008-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.